相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design, synthesis and antitumor evaluation of novel pyrazolo[3,4-d]pyrimidines incorporating different amino acid conjugates as potential DHFR inhibitors
Ibrahim M. Salem et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)
Coumarin derivatives with potential anticancer and antibacterial activity: Design, synthesis, VEGFR-2 and DNA gyrase inhibition, and in silico studies
Soha H. Emam et al.
DRUG DEVELOPMENT RESEARCH (2023)
Design and synthesis of novel hexahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives as potential anticancer agents with antiangiogenic activity via VEGFR-2 inhibition, and down-regulation of PI3K/AKT/mTOR signaling pathway
Safaa E. E. Seif et al.
DRUG DEVELOPMENT RESEARCH (2023)
Design, synthesis, anticancer, and antibacterial evaluation of some quinazolinone-based derivatives as DHFR inhibitors
Eman O. Osman et al.
DRUG DEVELOPMENT RESEARCH (2023)
Design, synthesis, anticancer evaluation, and in silico studies of some thieno[2,3-d]pyrimidine derivatives as EGFR inhibitors
Menna Tallah M. Sayed et al.
DRUG DEVELOPMENT RESEARCH (2023)
Design, synthesis and evaluation of anticancer activity of new pyrazoline derivatives by down-regulation of VEGF: Molecular docking and apoptosis inducing activity
Rasha A. Hassan et al.
BIOORGANIC CHEMISTRY (2022)
New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies
Hazem Elkady et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Synthesis and biological evaluation of halogenated phenoxychalcones and their corresponding pyrazolines as cytotoxic agents in human breast cancer
Peter A. Halim et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors
Abdallah E. Abdallah et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Pyrimidine-5-carbonitrile based potential anticancer agents as apoptosis inducers through PI3K/AKT axis inhibition in leukaemia K562
Nehad M. El-Dydamony et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Novel antiproliferative agents bearing substituted thieno[2,3-d]pyrimidine scaffold as dual VEGFR-2 and BRAF kinases inhibitors and apoptosis inducers; design, synthesis and molecular docking
Rasha A. Hassan et al.
BIOORGANIC CHEMISTRY (2022)
Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold with apoptotic activity
Asmaa A. Mandour et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation
Mohammed S. Taghour et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects
Eslam B. Elkaeed et al.
MOLECULES (2022)
Design and synthesis of novel quinazolinone-based derivatives as EGFR inhibitors with antitumor activity
Amr Sonousi et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Novel pyrazolo[3,4-d]pyrimidines as potential anticancer agents: Synthesis, VEGFR-2 inhibition, and mechanisms of action
Zukela Ruzi et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Coumarin-acetohydrazide derivatives as novel antiproliferative agents via VEGFR-2/AKT axis inhibition and apoptosis triggering
Lina M. A. Abdel Ghany et al.
NEW JOURNAL OF CHEMISTRY (2022)
Synthesis of Pyrazole-Carboxamides and Pyrazole-Carboxylic Acids Derivatives: Simple Methods to Access Powerful Building Blocks
Byanca Silva Ferreira et al.
LETTERS IN ORGANIC CHEMISTRY (2021)
Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers
Farag F. Sherbiny et al.
BIOORGANIC CHEMISTRY (2021)
Design, ecofriendly synthesis, anticancer and antimicrobial screening of innovative Biginelli dihydropyrimidines using β-aroylpyruvates as synthons
Afaf El-Malah et al.
GREEN CHEMISTRY LETTERS AND REVIEWS (2021)
Cancer statistics for the year 2020: An overview
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Pharmacophore-linked pyrazolo[3,4-d]pyrimidines as EGFR-TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies
Ahmed A. Gaber et al.
ARCHIV DER PHARMAZIE (2021)
Novel thienopyrimidine-aminothiazole hybrids: Design, synthesis, antimicrobial screening, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and VEGFR-2 inhibition
Yara El-Dash et al.
BIOORGANIC CHEMISTRY (2021)
Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers
Asmaa E. Kassab et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Novel pyrazolopyrimidine urea derivatives: Synthesis, antiproliferative activity, VEGFR-2 inhibition, and effects on the cell cycle profile
Asmaa E. Kassab et al.
ARCHIV DER PHARMAZIE (2020)
Novel Anticancer Fused Pyrazole Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors
Nashwa M. Saleh et al.
FRONTIERS IN CHEMISTRY (2020)
Conventional and microwave reactions of 1,3-diaryl-5,4-enaminonitrile-pyrazole derivative with expected antimicrobial and anticancer activities
Kurls E. Anwer et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2020)
Novel antiproliferative agents bearing morpholinopyrimidine scaffold as PI3K inhibitors and apoptosis inducers; design, synthesis and molecular docking
Amira A. Helwa et al.
BIOORGANIC CHEMISTRY (2020)
Part-II: Utilities of active methylene compounds and heterocycles bearing active methyl or having an active methine in the formation of bioactive pyrazoles and pyrazolopyrimidines
Mohamed Abdel-Megid
SYNTHETIC COMMUNICATIONS (2020)
Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity
Huda K. Mahmoud et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-d]pyrimidine scaffold
Daniel J. Baillache et al.
RSC MEDICINAL CHEMISTRY (2020)
Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis
Mai Maher et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Synthesis of 4,6-disubstituted pyrazolo[3,4-d ]pyrimidine analogues: Cyclin-dependent kinase 2 (CDK2) inhibition, molecular docking and anticancer evaluation
Srinivasulu Cherukupalli et al.
JOURNAL OF MOLECULAR STRUCTURE (2019)
Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors
Shaofeng Sun et al.
MOLECULES (2018)
Pyrazolo[3,4-d]pyrimidine derivatives containing a Schiff base moiety as potential antiviral agents
Yan-Yan Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d] pyrimidine derivatives as potent EGFRWT and EGFRT790m inhibitors and apoptosis inducers
Ahmed A. Gaber et al.
BIOORGANIC CHEMISTRY (2018)
Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents
Gina N. Tageldin et al.
BIOORGANIC CHEMISTRY (2018)
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy
Brandt C. Huddle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Paralog Specificity Determines Subcellular Distribution, Action Mechanism, and Anticancer Activity of TRAP1 Inhibitors
Hye-Kyung Park et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis and structure-activity relationship study of pyrazolo[3,4-d]pyrimidines as tyrosine kinase RET inhibitors
Chengyan Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Design, synthesis and antitumor activity of novel pyrazolo[3,4-d]pyrimidine derivatives as EGFR-TK inhibitors
Mohamed A. Abdelgawad et al.
BIOORGANIC CHEMISTRY (2016)
Design and discovery of 4-anilinoquinazoline-acylamino derivatives as EGFR and VEGFR-2 dual TK inhibitors
Hai-Qi Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl) phthalazine derivatives
Wagdy M. Eldehna et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Sunitinib: the antiangiogenic effects and beyond
Zhonglin Hao et al.
ONCOTARGETS AND THERAPY (2016)
Sorafenib: 10 years after the first pivotal trial
Gennaro Gadaleta-Caldarola et al.
FUTURE ONCOLOGY (2015)
FDA-approved small-molecule kinase inhibitors
Peng Wu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Synthesis and in vitro antiproliferative activity of novel pyrazolo[3,4-d]pyrimidine derivatives
Nermin S. Abdou et al.
MEDCHEMCOMM (2015)
Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery?
Zheng Zhao et al.
ACS CHEMICAL BIOLOGY (2014)
Effector mechanisms of sunitinib-induced G1 cell cycle arrest, differentiation, and apoptosis in human acute myeloid leukaemia HL60 and KG-1 cells
Chieh-Lin Jerry Teng et al.
ANNALS OF HEMATOLOGY (2013)
Caffeic acid phenethyl ester synergistically enhances docetaxel and paclitaxel cytotoxicity in prostate cancer cells
Mai F. Tolba et al.
IUBMB LIFE (2013)
Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors
Michele McTigue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Synthesis and in vitro cytotoxic activity of novel pyrazolo[3,4-d]pyrimidines and related pyrazole hydrazones toward breast adenocarcinoma MCF-7 cell line
Ghaneya Sayed Hassan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Angiogenesis Inhibitors: Current Strategies and Future Prospects
Kristina M. Cook et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Synthesis of some new pyrazolo[3,4-d]pyrimidine derivatives of expected anticancer and radioprotective activity
Mostafa M. Ghorab et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Sunitinib: A VEGF and PDGF receptor protein kinase and angiogenesis inhibitor
Robert Roskoski
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Synthesis and biological evaluations of pyrazolo[3,4-d] pyrimidines as cyclin-dependent kinase 2 inhibitors
DC Kim et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Cell cycle checkpoint signaling: Cell cycle arrest versus apoptosis
JA Pietenpol et al.
TOXICOLOGY (2002)
分享论文
